Gene therapy group awards $1.3 million for research in glioblastoma, sarcoma, and ovarian cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nori Kasahara

Seth Pollack

Daniel Powell

Three scientists received $1.3 million in funding from the Alliance for Cancer Gene Therapy, the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer. These grants will be used to study immunotherapy and virotherapy in the treatment of glioblastoma, sarcoma and ovarian cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The White House Office of Management and Budget has published a “Regulation for Federal Financial Assistance,” a proposed rule that seeks to fundamentally redraw the ground rules for all federally funded research. On the other side are America’s scientists who aren’t just crying foul—they are readying for a political fight.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login